Downregulating CREBBP inhibits proliferation and cell cycle progression and induces daunorubicin resistance in leukemia cells

Low expression levels of CREB-binding protein (CREBBP) have been demonstrated to be associated with high minimal residual disease at the end of induction therapy and adverse long-term outcomes in pediatric patients with acute lymphoblastic leukemia (ALL). However, the effect of low CREBBP expression...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Mol Med Rep
Autors principals: Gao, Chao, Liu, Shu-Guang, Lu, Wen-Ting, Yue, Zhi-Xia, Zhao, Xiao-Xi, Xing, Tian-Yu, Chen, Zhen-Ping, Zheng, Hu-Yong, Li, Zhi-Gang
Format: Artigo
Idioma:Inglês
Publicat: D.A. Spandidos 2020
Matèries:
Articles
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC7453649/
https://ncbi.nlm.nih.gov/pubmed/32945392
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3892/mmr.2020.11347
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars